Finance

Lists
Why is 300725 up 3.37%?
Dive Deeper
300725:SHE
PharmaBlock Sciences Nanjing Inc
CNÂ¥45.46
+3.37%
(+1.48) 1D
Oct 20, 3:04:28 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300725...
Open
CNÂ¥44.30
High
CNÂ¥46.13
Low
CNÂ¥42.71
Mkt. cap
10.28B
Avg. vol.
21.05M
Volume
20.77M
Dividend
0.53%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Aug 25, 2026
P/E ratio
48.85
52-wk high
CNÂ¥57.55
52-wk low
CNÂ¥30.90
EPS
CNÂ¥0.93
Shares outstanding
233.81M
No. of employees
3K
Open
CNÂ¥44.30
High
CNÂ¥46.13
Low
CNÂ¥42.71
Mkt. cap
10.28B
Avg. vol.
21.05M
Volume
20.77M
Dividend
0.53%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
Aug 25, 2026
P/E ratio
48.85
52-wk high
CNÂ¥57.55
52-wk low
CNÂ¥30.90
EPS
CNÂ¥0.93
Shares outstanding
233.81M
No. of employees
3K
News stories
From web sources and news partners
About PharmaBlock Sciences Nanjing Inc
CEO-
Employees2.59K
FoundedDec 26, 2006
Headquarters-
SectorPharmaceutical industry
Websitepharmablock.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
499.33M
555.42M
508.03M
551.43M
Cost of goods sold
310.52M
416.74M
344.74M
391.71M
Cost of revenue
310.52M
416.74M
344.74M
391.71M
Research and development expenses
30.69M
29.67M
29.81M
30.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61.35M
64.04M
65.83M
75.78M
Operating expense
94.22M
128.61M
96.71M
109.23M
Total operating expenses
404.74M
545.35M
441.46M
500.94M
Operating income
94.59M
10.07M
66.58M
50.48M
Other non operating income
-849.10K
623.93K
-12.44M
11.16M
EBT including unusual items
41.96M
79.37M
52.80M
61.00M
EBT excluding unusual items
96.04M
20.50M
61.83M
45.99M
Income tax expense
1.07M
9.03M
3.91M
10.44M
Effective tax rate
2.55%
11.38%
7.41%
17.12%
Other operating expenses
-1.99M
9.24M
-1.41M
5.91M
Net income
40.89M
70.34M
48.89M
50.56M
Net profit margin
8.19%
12.67%
9.62%
9.17%
Earnings per share
-
-
-
-
Interest and investment income
12.13M
13.93M
8.31M
7.28M
Interest expense
-9.86M
-
-618.48K
-649.04K
Net interest expenses
2.28M
13.93M
7.69M
6.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
126.78M
43.77M
100.27M
86.65M
Gain or loss from assets sale
-
-1.15M
-
-84.72K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps